Call 888-647-0579 to speak with an alcohol or drug abuse counselor.

Who Answers?

New Medications May Offer Hope to Drinkers Battling Alcohol Dependence

Individuals who experience the physical, mental and social symptoms associated with alcohol dependence are offered hope through the results of two recent studies by researchers at the Medical University of South Carolina (MUSC). In separate investigations, researchers found favorable results for a medication to help heavy drinkers who are trying to modify their consumption, as well as a medication to reduce alcohol withdrawal symptoms and prevent relapse.

In a landmark study, MUSC researchers working with investigators at the University of Virginia Health System and elsewhere have found that topiramate, an effective therapeutic medication, not only decreases heavy drinking, but it also lowers all liver enzymes, plasma cholesterol, body mass index (BMI), and systolic and diastolic blood pressure — all of which tend to increase with heavy drinking and pose such serious health risks as heart disease and cirrhosis. Notably, these combined effects suggest that topiramate may decrease the risk of heart disease in alcohol dependent individuals.

“These findings add growing data indicating that heavy drinkers who modify their drinking with the help of medication and supportive counseling may see an improvement in health and well-being, as well as a potential reduction of risk for the development of heart and liver diseases. This shows that treatment of alcoholism has potential health benefits beyond the immediate behavioral and emotional improvement caused by a reduction in drinking” said Raymond Anton, M.D., distinguished university professor.

By decreasing liver enzymes and cholesterol levels, topiramate also may reduce the risk of fatty liver disease, which leads to cirrhosis – a common consequence to end-stage liver disease leading to death in some alcoholics.

Additionally, topiramate significantly contributed to a decline in obsessive thoughts and compulsions, components of alcohol craving, and also had a greater improvement in their “overall quality of life,” and specifically an improvement in general and leisure activities and household duties, as well as a reduction in sleep disturbances.

The Food and Drug Administration has approved topiramate for seizures and migraine headaches, but it is not currently approved for treating alcohol dependence. Ortho-McNeil Neurologics, Inc., manufactures topiramate and provided study funding.

Results from the nationwide 14-week trial involving 371 male and female diagnosed alcoholics was published in the June 9 issue of the Archives of Internal Medicine.

In addition, Anton presented initial results from a separate investigation of a 14-week double-blind, placebo-controlled study utilizing the PROMETA ® alcoholism treatment program, developed by Hythiam, inc., at the 2008 Research Society on Alcoholism (RSA) conference in Washington D.C.

Anton suggested that alcohol dependence programs are few in number and not exceptionally effective, which is particularly true for individuals who experience alcohol withdrawal symptoms. PROMETA ®, a combination of generic medications, reduced cravings and alcohol withdrawal symptoms, promoted abstinence, and improved mood and sleep only in those who had symptoms of alcohol withdrawal. Although the PROMETA ® Protocol has been marketed nationally, this was the first scientific study examining its utility in individuals with alcohol dependence.

At the time of the RSA presentation, the data presented covered the initial six-week active treatment phase of the 14-week study. While these are initial findings, additional evaluation of the full 14-week study data is ongoing, and Anton plans to release these specifics in a peer-reviewed publication.

MUSC has an ongoing clinical trial program studying new medications for the treatment of alcohol use disorders. For more information call 843-792-2727.
__________
source: Newswise Medical News

More Treatment & Detox Articles

Outpatient Versus Inpatient Drug Treatment Centers

Are you wondering if you should seek outpatient treatment rather than inpatient treatment? There are many factors that you must consider when you begin searching for treatment centers such as the level of your addiction, the level of support that you have at home, and also the type of addiction that you suffer from. If….

Alcohol Check-In Sees Record Crowd

Drawn by the promise of free water bottles, more than 1,330 students flocked to the Malkin Athletic Center last Friday for National Alcohol Screening Day, marking a record level of participation that rose by almost 40 percent from last year. The annual event, which takes place at hospitals, community centers, and universities around the country,….

Opiate detox

Opiate intake regularly can lead to disorders related to the central nervous system. In an opiate addiction, the person is habitual to taking opiate drugs for “pain management”. This constant use of the opiates, affects the functioning of the nerve cells that results in the end of the “natural endorphins” production, which are capable of….

Recognizing the Need for Alcohol Treatment Centers

Compared to drug addiction treatment rates, alcoholism is the most untreated disease in the U.S., according to the Florida Institute of Technology. On average, only 1 out of every 36 people suffering from alcoholism actually gets help. Though alcoholism is officially classified as a disease, it’s a treatable condition. Alcohol treatment centers specialize in applying….

Study: Regular Alcohol Consumption Leads To Binge Drinking

A new study made by researchers at the University of Montreal and University of Western Ontario showed regular alcohol consumption increases the chance of binge drinking. The report, published in the journal Addiction, was based on close monitoring of 11,000 Canadian respondents the past year of their alcohol drinking habits and patterns. The 11,000 was….